Porównaj metody

	Analiza Różnicowa Metabolomiki	Analiza wzbogacenia szlaków
Dziedzina	Bioinformatyka	Bioinformatyka
Rodzina	Process / pipeline	Process / pipeline
Rok powstania	2000s–2010s (field formalised alongside mass spectrometry advances)	2003–2005
Twórca	Developed through convergent contributions by multiple groups; XCMS (Siuzdak lab, 2006) and MetaboAnalyst (Wishart lab, 2009–2015) are foundational computational implementations	Mootha et al. (2003); systematised by Subramanian et al. (2005)
Typ	Quantitative comparative omics pipeline	Statistical functional annotation method
Źródło pierwotne	Xia, J., Sinelnikov, I. V., Han, B., & Wishart, D. S. (2015). MetaboAnalyst 3.0 — making metabolomics more meaningful. Nucleic Acids Research, 43(W1), W251–W257.	Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., & Mesirov, J. P. (2005). Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences, 102(43), 15545–15550.
Inne nazwy	comparative metabolomics, differential metabolite profiling, metabolomic differential analysis, DMA	PEA, overrepresentation analysis, ORA, functional enrichment analysis
Pokrewne	6	6
Podsumowanie	Differential metabolomics analysis is a computational pipeline that identifies metabolites whose abundance levels differ significantly between two or more biological conditions — such as disease versus control, treated versus untreated, or different developmental stages. By integrating mass spectrometry or NMR data with statistical modelling and pathway databases, it translates raw spectral measurements into biologically interpretable lists of perturbed metabolic features and the pathways they implicate.	Pathway enrichment analysis (PEA) is a statistical approach that takes a list of genes or proteins of interest — typically derived from a differential expression or proteomics experiment — and identifies which pre-defined biological pathways or functional gene sets are represented more often than expected by chance. By mapping individual molecular changes onto curated pathway knowledge bases such as KEGG, Gene Ontology, or Reactome, PEA translates long gene lists into interpretable biological processes, making it a central tool in the post-analysis of high-throughput omics experiments.